annamycin
|
|
annamycin Eigenschaften
- Siedepunkt:
- 822.1±65.0 °C(Predicted)
- Dichte
- 1.94±0.1 g/cm3(Predicted)
- pka
- 7.75±0.60(Predicted)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alarmwort | Achtung | ||||||||||||||||||||||||||||
Gefahrenhinweise |
|
||||||||||||||||||||||||||||
Sicherheit |
|
annamycin Chemische Eigenschaften,Einsatz,Produktion Methoden
annamycin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
annamycin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 9)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 |
sales@molcore.com | China | 49734 | 58 |
Hu Bei Jiutian Bio-medical Technology CO.,Ltd | 027-88013699 17354350817 |
Ryan@jiutian-bio.com | China | 6001 | 58 |
TargetMol Chemicals Inc. | +8613564774135 |
zijue.cai@tsbiochem.com | United States | 19881 | 58 |
Shenzhen Botel Biotechnology Co. Ltd. | 13316949107 13316968096 |
1979313431@qq.com | China | 9120 | 58 |
Changzhou Bojia Biomedical Technology Co., Ltd. | 2122619822 |
czbjpharma@126.com | China | 18478 | 58 |
Beijing Qinling Pharmaceutical Co., Ltd. | 010-61241352 18901327973 |
834537306@qq.com | China | 5205 | 58 |
TargetMol Chemicals Inc. | 15002134094 |
marketing@targetmol.cn | China | 19699 | 58 |
Cato Research Chemicals Inc. | 13342851930 |
3008394369@qq.com | China | 15726 | 58 |
Carbosynth | -- |
sales@carbosynth.com | United Kingdom | 6005 | 58 |
92689-49-1()Verwandte Suche:
- annamycin
- (7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-Dihydroxy-3-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
- 5,12-Naphthacenedione, 7-[(2,6-dideoxy-2-iodo-α-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-, (7S,9S)-
- 5,12-Naphthacenedione,7-[(2,6-dideoxy-2-iodo-a-L-mannopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-,(7S,9S)-
- 92689-49-1
- C26H25IO11